Sofinnova Investments, Inc. Arcus Biosciences, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$19.7 - $35.71 $1.31 Million - $2.38 Million	-66,534 Reduced 17.45%	314,811 $6.51 Million
Q3 2022 Nov 08, 2022	BUY	$23.23 - $30.07 $8.86 Million - $11.5 Million	381,345 New	381,345 $9.98 Million
Q1 2021 May 14, 2021	SELL	$26.16 - $41.39 $4.87 Million - $7.71 Million	-186,278 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $3.17 Million - $6.03 Million	186,278 New	186,278 $4.84 Million

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.